Truscreen Group Ltd (TRU) - Total Liabilities

Latest as of September 2025: AU$951.80K AUD ≈ $673.46K USD

Based on the latest financial reports, Truscreen Group Ltd (TRU) has total liabilities worth AU$951.80K AUD (≈ $673.46K USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Truscreen Group Ltd (TRU) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Truscreen Group Ltd - Total Liabilities Trend (2013–2024)

This chart illustrates how Truscreen Group Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see TRU current and non-current assets.

Truscreen Group Ltd Competitors by Total Liabilities

The table below lists competitors of Truscreen Group Ltd ranked by their total liabilities.

Company Country Total Liabilities
Reward Minerals Ltd
AU:RWD
Australia AU$7.59 Million
Highfield Resources Ltd
F:23H
Germany €75.84 Million
Belararox Ltd
AU:BRX
Australia AU$4.97 Million
mTouche Technology Bhd
KLSE:0092
Malaysia RM19.25 Million
Errawarra Resources Ltd
AU:ERW
Australia AU$519.35K
Datasea Inc
NASDAQ:DTSS
USA $7.52 Million
Ecclesiastical Insurance Office plc
LSE:ELLA
UK GBX624.10 Million
Forza Land Indonesia Tbk PT
JK:FORZ
Indonesia Rp305.17 Billion

Liability Composition Analysis (2013–2024)

This chart breaks down Truscreen Group Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Truscreen Group Ltd's balance sheet to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 5.05 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.28 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.22 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Truscreen Group Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Truscreen Group Ltd (2013–2024)

The table below shows the annual total liabilities of Truscreen Group Ltd from 2013 to 2024.

Year Total Liabilities Change
2024-12-31 AU$839.98K
≈ $594.34K
+5.20%
2023-12-31 AU$798.45K
≈ $564.95K
-13.98%
2022-12-31 AU$928.16K
≈ $656.73K
-6.43%
2021-12-31 AU$991.89K
≈ $701.83K
+42.62%
2020-12-31 AU$695.50K
≈ $492.11K
-16.50%
2019-12-31 AU$832.94K
≈ $589.36K
-32.00%
2018-12-31 AU$1.22 Million
≈ $866.73K
+122.33%
2017-12-31 AU$550.97K
≈ $389.84K
-23.18%
2016-12-31 AU$717.19K
≈ $507.46K
+67.01%
2015-12-31 AU$429.43K
≈ $303.85K
-45.45%
2014-12-31 AU$787.21K
≈ $557.00K
-28.32%
2013-12-31 AU$1.10 Million
≈ $777.05K
--

About Truscreen Group Ltd

AU:TRU Australia Medical Devices
Market Cap
$5.82 Million
AU$8.22 Million AUD
Market Cap Rank
#28394 Global
#1483 in Australia
Share Price
AU$0.01
Change (1 day)
+0.00%
52-Week Range
AU$0.01 - AU$0.02
All Time High
AU$0.16
About

TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, and the Middle East/North Africa. It offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The comp… Read more